For years, one of the most powerful weapons against certain blood cancers, called CAR-T therapy, has required an elaborate process: Doctors extract a patient’s immune cells, ship them to a specialized ...

Tesla is expanding ties with LG Energy Solution and has agreed to buy $4.3 billion worth of battery cells produced in Lansing, Michigan for energy storage systems. The cells will be made by LG at a ...

Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology. “We are very ...

President Donald Trump hailed the swift prosecution of the military campaign against Iran, but acknowledged there are terrorist "sleeper cells" in the U.S. that have to be watched and dealt with.

Biotech startup Cortical Labs is working on two small data centers run by human brain cells, putting lab-grown neurons onto silicon in an experiment that could one day challenge chips from the likes ...

Abstract: In this letter, we investigate cooperative multi-cell integrated sensing and communications (ISAC) systems with multi-array base stations (BSs). First, we explore the relations among ...

A pair of new studies have provided fresh evidence in the long-running scientific debate—and the result could be game-changing for treating diseases like Alzheimer’s and dementia. For decades ...

Scientists have built a massive cellular atlas showing how aging reshapes the body across 21 organs. Studying nearly 7 million cells, they found that aging starts earlier than expected and unfolds in ...

Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her knowledge in 1951 and ...

Ms. Lacks’s family accused Novartis of profiting from her cells, which were taken from her without her consent in 1951, when she was dying of cervical cancer. By Michael Levenson The pharmaceutical ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Let’s say it’s 2036, and scientists are working on a new class of drugs. These medications are mirror-image versions of the molecules your body uses to fight disease. Their big advantage is that ...